Vivanza Biosciences Limited Share Price

Vivanza Biosciences Limited Share Price

BSE: 530057
|
Trading
|
S Cap
₹ 1.80
-₹0.05 (-2.7%)
1D
Last updated 23 Sep, 2026, 15:15 IST

Vivanza Biosciences Limited Share Price Today

As of 24 Sep 2026, Vivanza Biosciences Limited share price is ₹1.80. The stock opened at ₹1.85, compared to its previous close of ₹1.85. During today's trading session, Vivanza Biosciences Limited share price moved in the range of ₹1.80 to ₹1.85, with an average price of ₹1.83 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.52 and a high of ₹2.72.

₹1.80
2.70% down today
₹1.85
1D LOW
1D HIGH

Vivanza Biosciences Limited Returns Calculator

Circuit
L
H
₹1.48
₹2.22
52-week
L
H
₹1.52
₹2.72

About Vivanza Biosciences Limited

Vivanza Biosciences Limited Share Price
ISIN
INE984E01035
Sector Market Cap
₹ 7.40 Cr

Vivanza Biosciences Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of pharmaceutical products. Its products include gloves and surgical. Its Gloves products include latex examination gloves powdered, latex surgical powder free, latex free examination gloves-vinyl, latex free examination gloves-nitrile, and latex surgical powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves, Therapeutic Index Injection, Veterinary Product, and Veterinary Feed. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.

Vivanza Biosciences Limited Financial Highlights

  • Revenue: Vivanza Biosciences Limited reported revenue of ₹116.02 crore in FY26 vs ₹7.48 crore in FY25. It showed an increase of 1,451.07% on a yearly basis.
  • Operating Profit: Vivanza Biosciences Limited reported an operating profit of ₹0.54 crore in FY26 vs ₹0.67 crore in FY25. It showed an increase of 180.60% on a year-on-year basis.
  • Net Profit: Vivanza Biosciences Limited reported a net profit of ₹0.39 crore in FY26 vs ₹0.67 crore in FY25. It showed an increase of 158.21% on a yearly basis.

Vivanza Biosciences Limited Quarterly Result Highlights

  • Vivanza Biosciences Limited reported revenue of ₹9.66 crore in Jun 2026, compared with ₹6.37 crore in Mar 2026, representing an increase of 51.65% on a quarter-on-quarter (QoQ) basis.
  • Vivanza Biosciences Limited reported an operating profit of ₹0.18 crore in Jun 2026, compared with ₹0.30 crore in Mar 2026, representing an increase of 160.00% on a quarter-on-quarter (QoQ) basis.
  • Vivanza Biosciences Limited reported a profit of ₹0.15 crore in Jun 2026, compared with ₹0.45 crore in Mar 2026, reflecting an increase of 133.33% on a QoQ basis.
  • The earnings per share (EPS) of Vivanza Biosciences Limited stood at ₹0.10 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
20.02%
FII
0.00%
Other DII
0.00%
Retail and other
79.98%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
7.40
P/E
16.36
P/B
1.65
ROE
9.05%
D/E
1.71
ROCE
5.66%
Div. Yield
0.00%
EPS(TTM)
0.09
Turnover
6.23
EV/EBITDA
18.07
Net Margin
0.34%
Op. Margin
0.73%
ROA
2.08%
Quick Ratio
0.98
Curr. Ratio
2.46
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Vivanza Biosci. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Vivanza Biosci. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Vivanza Biosci. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Vivanza Biosciences Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹115.91₹7.42₹27.84₹17.81
Other Income₹0.11₹0.06₹0.05₹0.48
Total Revenue₹116.02₹7.48₹27.89₹18.28
Total Expenses₹115.48₹8.15₹27.19₹17.57
Profit Before Tax₹0.54-₹0.67₹0.70₹0.72
Tax₹0.15₹0.01₹0.15₹0.12
Profit After Tax₹0.39-₹0.67₹0.55₹0.60
EPS - Basic₹0.10-₹0.17₹0.14₹1.50
EPS - Diluted₹0.10-₹0.17₹0.14₹1.50

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.54-₹0.67₹0.70₹0.72
Income before WC changes₹0.84-₹0.30₹1.12₹1.14
Change in Assets-₹4.52₹3.01₹0.52-₹4.63
Change in Liabilities₹1.24-₹5.20₹0.55₹2.66
Change in WC-₹3.28-₹2.19₹1.07-₹1.97
Cash flow from Operations-₹2.58-₹2.50₹2.04-₹0.95
Cash flow from Investing-₹0.12-₹0.01-₹0.04₹0.00
Cash flow from Financing₹2.65₹2.46-₹1.98₹1.03
Total Cash Flow-₹0.05-₹0.05₹0.03₹0.09
Cash (Start of the year)₹0.12₹0.17₹0.14₹0.06
Cash (End of the year)₹0.07₹0.12₹0.17₹0.14

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3.03₹4.07₹3.76₹2.92
Current Assets₹19.05₹12.38₹15.74₹19.55
Total Assets₹22.09₹16.45₹19.50₹22.48
Current Liabilities₹16.85₹9.15₹12.18₹16.95
Net Current Asset₹2.20₹3.23₹3.56₹2.60
Non-Current Liabilities₹0.88₹3.33₹2.68₹1.43
Equity Capital₹4.36₹3.96₹4.64₹4.09
Total Equity & Liabilities₹22.09₹16.45₹19.50₹22.48

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹112.23₹2.94₹14.41₹14.21
Other Income₹0.11₹0.03₹0.05₹0.39
Total Revenue₹112.34₹2.98₹14.47₹14.59
Total Expenses₹111.82₹3.67₹14.04₹13.91
Profit Before Tax₹0.52-₹0.69₹0.43₹0.69
Tax₹0.14₹0.00₹0.11₹0.12
Profit After Tax₹0.38-₹0.70₹0.32₹0.57
EPS - Basic₹0.09-₹0.17₹0.08₹1.42
EPS - Diluted₹0.09-₹0.17₹0.08₹1.42

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.52-₹0.69₹0.43₹0.69
Income before WC changes₹0.82-₹0.33₹0.85₹1.11
Change in Assets-₹4.42₹2.95₹1.64-₹4.35
Change in Liabilities₹2.53-₹5.09-₹0.59₹3.52
Change in WC-₹1.89-₹2.14₹1.05-₹0.83
Cash flow from Operations-₹1.21-₹2.47₹1.80₹0.16
Cash flow from Investing-₹0.12-₹0.01-₹0.04₹0.00
Cash flow from Financing₹1.31₹2.44-₹1.77-₹0.08
Total Cash Flow-₹0.03-₹0.04-₹0.01₹0.09
Cash (Start of the year)₹0.05₹0.09₹0.10₹0.02
Cash (End of the year)₹0.02₹0.05₹0.09₹0.10

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2.63₹2.53₹2.54₹2.51
Current Assets₹15.59₹11.38₹14.33₹17.93
Total Assets₹18.23₹13.91₹16.87₹20.44
Current Liabilities₹12.95₹9.12₹11.38₹16.04
Net Current Asset₹2.64₹2.27₹2.95₹1.89
Non-Current Liabilities₹0.88₹0.78₹0.78₹0.00
Equity Capital₹4.40₹4.02₹4.72₹4.40
Total Equity & Liabilities₹18.23₹13.91₹16.87₹20.44
* All values are in INR Crore
Qty
Bid
1
1.8
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 1
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
0
Neutral
6
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.61
Neutral
ATR (14)
0.08
Neutral
STOCH(9,6)
50
Neutral
STOCH RSI (14)
42.57
Neutral
ADX(9)
15.87
Bullish
UO(9)
39.53
Neutral
ROC(12)
2.86
Bullish
WillR(14)
-50
Neutral
Period
Simple value
Exponential vaue
5D
1.8
1.81
10D
1.81
1.8
20D
1.79
1.8
50D
1.82
1.82
100D
1.84
1.86
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Vivanza Biosciences Limited Share Price
Vivanza Biosciences Limited
Trading
Add Stock
Add Another

Vivanza Biosciences Limited Share Price FAQs

Vivanza Biosciences Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837